SPRO - Spero Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Cambridge,
United States
Type: Equity
SPRO price evolution
SPRO
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76.33 | $93.83 | $77.69 | $96.25 |
| Short term investments | ||||
| Net receivables | $97.29 | $2.99 | $2.09 | $1.86 |
| Inventory | ||||
| Total current assets | $131.21 | $102.22 | $88.35 | $101.66 |
| Long term investments | ||||
| Property, plant & equipment | $4.16 | $4.45 | $4.8 | $5.14 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $51.18 | $4.88 | $10.54 | $10.88 |
| Total investments | ||||
| Total assets | $182.39 | $107.1 | $98.89 | $112.55 |
| Current liabilities | ||||
| Accounts payable | $1.38 | $1.1 | $1.31 | $0.58 |
| Deferred revenue | $61.54 | $37.63 | $31.01 | $31.8 |
| Short long term debt | $1.72 | $1.71 | $1.7 | $1.7 |
| Total current liabilities | $37.15 | $25.46 | $17.32 | $22.99 |
| Long term debt | $3.83 | $4.12 | $4.41 | $4.68 |
| Total noncurrent liabilities | $38.34 | $27.93 | $26.78 | $24.72 |
| Total debt | $5.54 | $5.83 | $6.11 | $6.38 |
| Total liabilities | $75.5 | $53.4 | $44.1 | $47.71 |
| Shareholders' equity | ||||
| Retained earnings | -$391.07 | -$442.26 | -$439.06 | -$427.14 |
| Other shareholder equity | ||||
| Total shareholder equity | $106.89 | $53.7 | $54.78 | $64.84 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76.33 | $109.11 | $112.58 | $85.21 |
| Short term investments | $33.82 | $41.7 | ||
| Net receivables | $97.29 | $1.08 | $2.28 | $5.33 |
| Inventory | ||||
| Total current assets | $131.21 | $113.57 | $157.87 | $139.15 |
| Long term investments | ||||
| Property, plant & equipment | $4.16 | $5.49 | $7.56 | $8.78 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $51.18 | $11.23 | $13.2 | $14.31 |
| Total investments | $33.82 | $41.7 | ||
| Total assets | $182.39 | $124.8 | $171.07 | $153.45 |
| Current liabilities | ||||
| Accounts payable | $1.38 | $0.62 | $1.1 | $1.16 |
| Deferred revenue | $61.54 | $32.53 | $10.64 | |
| Short long term debt | $1.72 | $1.69 | $1.36 | $0.95 |
| Total current liabilities | $37.15 | $21.65 | $18.67 | $14.34 |
| Long term debt | $3.83 | $4.96 | $5.97 | $6.89 |
| Total noncurrent liabilities | $38.34 | $27.22 | $64.11 | $7.07 |
| Total debt | $5.54 | $6.65 | $7.33 | $7.84 |
| Total liabilities | $75.5 | $48.87 | $82.78 | $21.41 |
| Shareholders' equity | ||||
| Retained earnings | -$391.07 | -$413.88 | -$367.46 | -$277.71 |
| Other shareholder equity | -$0 | -$0.01 | ||
| Total shareholder equity | $106.89 | $75.93 | $88.29 | $132.04 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $73.52 | $25.47 | $2.72 | $2.07 |
| Cost of revenue | ||||
| Gross Profit | $73.52 | $25.47 | $2.72 | $2.07 |
| Operating activities | ||||
| Research & development | $16.56 | $16.39 | $9.51 | $8.98 |
| Selling, general & administrative | $6.43 | $5.71 | $6.1 | $7.32 |
| Total operating expenses | $22.99 | $27.41 | $15.61 | $16.3 |
| Operating income | $50.53 | -$1.93 | -$12.89 | -$14.23 |
| Income from continuing operations | ||||
| EBIT | $51.58 | -$0.99 | -$11.91 | -$13.27 |
| Income tax expense | $0.39 | $2.21 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | $51.19 | -$3.21 | -$11.91 | -$13.27 |
| Income (for common shares) | $51.19 | -$3.21 | -$11.91 | -$13.27 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $103.78 | $53.51 | $18.26 | $9.33 |
| Cost of revenue | ||||
| Gross Profit | $103.78 | $53.51 | $18.26 | $9.33 |
| Operating activities | ||||
| Research & development | $51.44 | $47.59 | $64.53 | $67 |
| Selling, general & administrative | $25.55 | $36.48 | $41.7 | $21.44 |
| Total operating expenses | $82.3 | $95.71 | $106.23 | $88.44 |
| Operating income | $21.48 | -$42.2 | -$87.97 | -$79.11 |
| Income from continuing operations | ||||
| EBIT | $25.4 | -$43.81 | -$87.82 | -$78.28 |
| Income tax expense | $2.6 | |||
| Interest expense | $2.6 | $1.94 | ||
| Net income | ||||
| Net income | $22.81 | -$46.41 | -$89.76 | -$78.28 |
| Income (for common shares) | $22.81 | -$46.41 | -$89.76 | -$78.28 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $51.19 | -$3.21 | -$11.91 | -$13.27 |
| Operating activities | ||||
| Depreciation | $0.04 | $0.11 | $0.11 | $0.11 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2 | $1.91 | $1.86 | $2.17 |
| Total cash flows from operations | -$17.49 | $15.91 | -$18.56 | -$12.85 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0 | $0.22 | ||
| Net borrowings | ||||
| Total cash flows from financing | $0 | $0.22 | ||
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$17.49 | $16.14 | -$18.56 | -$12.85 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $22.81 | -$46.41 | -$89.76 | -$78.28 |
| Operating activities | ||||
| Depreciation | $0.37 | $0.87 | $0.65 | $0.76 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.93 | $9.12 | $9.43 | $4.89 |
| Total cash flows from operations | -$32.99 | -$7.73 | -$64.35 | -$85.87 |
| Investing activities | ||||
| Capital expenditures | -$0.16 | |||
| Investments | $33.81 | $7.63 | $10.63 | |
| Total cash flows from investing | $33.81 | $7.67 | $10.47 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.22 | $24.93 | $36.82 | $80.85 |
| Net borrowings | -$54.48 | |||
| Total cash flows from financing | $0.22 | -$29.55 | $84.05 | $130.88 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$32.77 | -$3.48 | $27.38 | $55.48 |
News
Fundamentals
| Market cap | $86.92M |
|---|---|
| Enterprise value | $16.13M |
| Shares outstanding | 53.00M |
| Revenue | $103.78M |
|---|---|
| EBITDA | $25.77M |
| EBIT | $25.40M |
| Net Income | $22.81M |
| Revenue Q/Q | 54.98% |
| Revenue Y/Y | 93.95% |
| P/E ratio | 3.81 |
|---|---|
| EV/Sales | 0.16 |
| EV/EBITDA | 0.63 |
| EV/EBIT | 0.63 |
| P/S ratio | 0.84 |
| P/B ratio | 0.81 |
| Book/Share | 2.02 |
| Cash/Share | 1.44 |
| EPS | $0.43 |
|---|---|
| ROA | 18.21% |
| ROE | 32.55% |
| Debt/Equity | 0.71 |
|---|---|
| Net debt/EBITDA | -0.03 |
| Current ratio | 3.53 |
| Quick ratio | 3.53 |